相关实验视频
Updated: Jun 17, 2025

05:39
Spontaneous Murine Model of Anaplastic Thyroid Cancer
Published on: February 3, 2023
1.6K
临床,病理和免疫组织化学预测器的因果特异性死亡率在乳头甲状腺癌:多变量分析
M A Bakarev1, A A Ivanov2, E L Lushnikova2
1Federal Research Center of Fundamental and Translational Medicine, Novosibirsk, Russia. pathol@inbox.ru.
Bulletin of experimental biology and medicine
|August 12, 2024
概括
预测乳头甲状腺癌死亡率涉及诸如Hsp70表达,囊入侵,Ki-67指数和年龄等关键因素. 这项研究确定了新的预后模型的关键元素.
科学领域:
- 在瘤学瘤学.
- 病理学 病理学 病理学
- 免疫组织化学 免疫组织化学
背景情况:
- 乳头甲状腺癌 (PTC) 的预后有很大的差异.
- 确定因特定原因死亡率的可靠预测因素对于患者管理至关重要.
研究的目的:
- 分析PTC的临床,病理和免疫组织化学特征与特定原因死亡率之间的关联.
- 开发和验证一个预后模型,用于预测PTC患者的致命结果.
主要方法:
- 来自阿尔泰地区瘤中心的PTC患者队列中的病例控制研究.
- 多变量分析以确定死亡率的独立预测因素.
- 预后模型的开发和统计验证.
主要成果:
- 在PTC中10年因特定原因死亡率的独立预测因素包括核Hsp70表达模式,甲状腺囊入侵,Ki-67表达指数>7%,年龄 (男性>45岁,女性>50岁).
- 开发的预后模型显示出高统计意义 (χ2=64.73;p<0.001) 和优异的区分能力 (AUC=0.950,预测准确率为88.5%).
结论:
- 确定的临床,病理和免疫组织化学因素是PTC死亡率的重要预测因素.
- 开发的预后模型显著改善了乳头甲状腺癌的个体预后性能.
相关概念视频
Cancer Survival Analysis
334
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
334
Comparing the Survival Analysis of Two or More Groups
166
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
166

